Introduction: Osteoarthritis (OA) represents an increasing health issue worldwide. Regenerative medicine (RM) has raised the hope for introducing revolutionary therapies in clinical practice. Detection of autologus cell sources can improve accessibility to RM strategies.
INTRODUCTION
Osteoarthritis, the "progressive degenerative distruction of articular cartilage" represents the major cause of motor disability in both the developed and developing world [1] . With population aging, as well as with increased younger population physical activity, the prevalence of osteoarthritis is increasing worldwide [2] . Joint recostructive surgery, the ultimate treatment for advanced stages of joint destruction, is succesful in restoring mobility and aleviating pain in elderly [3] . Taking advantage of cutting edge research in the field of cell and developmental biology, molecular genetics, nano and comopsite biomaterials, regenerative medicine (RM) promotes biological treatments "focused on the repair, replacement and regeneration of cells, tissue or organs" [4] . RM aims not only simptom relief or mechanical substitution but to anatomically and functionally recompose living structures. The main actors of regenerative strategies are living cells, sought to be used in different technical contexts in order to recompose the lost, disabled or degenerated tissues or organs. Autologus chondrocyte implantation (ACT) and matrix assisted chondrocyte implantation (MACI) [5, 6] are RM therapies addressing focal cartilage defects. Several drawbacks are encountered using adult chondrocytes as cell source: limited number of cells, donor site pathology [7] , failure of cultured cells to attain an adequate level of differentiation. Stem cells with higher proliferative potential and pehnotypically stable can be used for cartilage regeneration [8] . For reasons of biological potential and accesibility, mesenchymal stem cells (MSC) are valuable sources for regenerative therapies [9] . Bone marrow derived stem cells (BMMSC), the first isolated and described [10] were the first to be tested for musculoskeletal regeneration [11] .
Ubiquitous mensenchymal tissues contain MSC with comparable proliferative and differentiation potential with BMMSCs [12] and have similar regenerative potential [13] . Adipose derived MCSs (ADSCs) are easy to obtain with less donor site pathology, are more abundant within the tissue, therefore regarded as important cell source for regenerative strategies [14, 15] .
Stem cells derived from synovial layer [16] , trabecular bone [17, 18] have been reported to be suitable for cartilage regeneration. Progenitor cells within osteoarthritic cartilage and other mesenchymal osteoarthritic tissues have been described in terms of their potential for in situ regeneration [19] [20] [21] . It has been presumed that OA occurrence and progression could be a process of uncoordinated growth [22, 23] . In this respect, articular and periarticular progenitor cell phenotype characterization is as important for disease pathogeny elucidation as it is for detecting autologus cell sources.
Recently described MSC anti-inflammatory and immunomodulatory properties justified their use in clinical trials for the treatment of graft versus host disease [24, 25] , Autologus MSCs cell therapy could be designed for controlling joint inflamatorry processes.
In the quest for easy acessible autologus MSCs to be used in different RM techniques, aim of this study was to isolate and characterize MSCs from articular and periarticular tissues of adult subjects in late stages of knee OA. Isolated cells were assesed in terms of proliferative potential, surface cell markers and three lineage differentiation (osteogenesis, adipogenesis and chondrogenesis).
MATERIAL AND METHODS.
Tissue sample collection, tissues were collected from patients undergoing total knee replacement (TKR, Merlin General Hospital, Galway, Ireland) after institutional ethical committee approval and patient informed consent. Inclusion criteria were osteoarthritis of the knee, primary TKR procedure, absence of recorded metabolic disease (diabetus melitus). Synovial tissue (Syn) from nonfatty synovium was minced with a scalpel and enzymatically digested (collagenase type I Sigma Aldrich) 1,5mg/ml/g, 6 hours on a shaker (Heidolph Titramax, Heidolph Instruments, Schwabach, Germany) at 300 rpm in incubator (37 0 C , 5% CO2). Digested tissue was filtered twice (100 m and 70 m cell strainers .BD Falcon, Bedford, MA) mononuclear cells counted and plated as primary culture. Adipose tissue (Adipo) was collected from subcutaneous fat, enzymatically digested (1mg/ml/g tissue) 6 hours using the same protocol as described for synovium. Trabecular bone was colected from the subcondral bone.. Mechanical cell extraction was performed by centrifugation 5,000 rpm, 8 min, 4 0 C). Mononuclear cells extracted were plated as P0 (BS cells). Bone chips were further digested using collagenase type I, 3mg/ml, 3 hours, mononuclear cells plated as P0 (BC cells).
Colony Forming Unit (CFU-F) assay, 10,000 cells from each sample and donor were plated in T75 flasks until apparition of visible colonies (> than 100 cells/colony). Colonies were counted in the culture flask, using an optical microscope at x4 magnification and a grid.
Cell culture. Primary culture (P0) was plated at 50,000 cells/cm 2 in complete MEM with 4 l/100 ml media recombinant human Fibroblast Growth Factor, ( FGF, Prepotech, London, UK). Subcultures were plated at 5,000 cells/cm 2 .
Cumulative population doubling. Cell population doubling (PD) calculation was performed using the formula PD= (LOG (N2)-LOG (N1))/LOG (2) N1 being the number of cells at confluence prior to re-plating and N2 number of re-plated cells. For quantitative chondrogenesis evaluation, total amount of GAG (glycozaminoglycans) was assessed using chondroitin-6-sulphate DMMB (1, 9 Dimethylmethylene blue) method; results were normalized for total DNA content using QuantiT Pico Green dsDNA assay (Invitrogen).
Flow cytometry
Life imaging and cell movement characteristics. P4 thawed cells were plated at 2,000 cells/cm 2 in 60 cm 2 Petri dishes, exposed to life imaging microscope (Olympus IX51 Inverted Fluorescent Microscope) for 24 hours. Cell velocity, acceleration and distance was calculated using Image Pro software (Image Pro 6.0, Media Cybernetics Inc.) Statistical analysis. Unless otherwise stated, data obtained are given as means ± SD. Between-group and withingroup differences were considered significant at p < 0.05 (n = 4). Multiple one and two-way analysis of variance (ANOVA, OriginLab PRO version 8.0) with group factor and repeated measures followed by Bonferroni post hoc analysis.
RESULTS

Patient demographics and cell yield.
The inclusion criteria selected a serial of elderly subjects. Mean patient age was 69±8 years; (n=4), range 59 -78; female -male ratio; 3:1. Wet weight of all processed tissues was mean 3.28 gr for all tissues collected. Maximum amount of tissue was collected from trabecular bone (5.4gr) and minimum (0.7 gr) from subcutaneous adipose tissue with no statistical significant differences between donors or tissue type ( Table  1) .
Total cell yield. 1x10
6 of four different cell types from each donor were re-plated at the end of each passage, remainder cells were cryopreserved. Thawed cell were partially used for flow cytometry, differentiation assays and life imaging. Highest cell yield per tissue weight (mean 19.29 x10 6 cells) resulted from expansion of adipose derived cells and lowest from bone (BS, 5.2x10 6 cells). No significant difference between the cell yield/tissue unit from different patients or tissue types was found. Remarkable, the number of Adipo cells/gr tissue from one donor was 2.38 times higher than mean Adipo cells from all donors (Table 2A) .
Cell morphology and CFU Cells derived from the three tissue types were morphologically distinct in culture (Fig. 1) . BS and BC cells have spindle shaped cellular body, form distinct colonies, slower to reach confluence. Syn cells have rectangular cellular bodies, form rapidly confluent colonies; Adipo cells are polygonal, with broad cellular bodies, Growth kinetics. BS and BC were slower to grow in primary culture (10-14 days) compared to Adipo and Syn cells (5-6 days). After passage 2, time in culture was similar for all tissues and donors. Population doublings PD and CPD was significant higher for passage 3 and 4 compared to 1 and 2 for all donors and tissues. Remarkable, the only significant donor dependent PD0 and CPD variability was recorded for Adipo cells (p 0, 05) ( Table 3, Table 2 Supplementary material).
Flow cytometry analysis. All cells were highly positive for Cluster of Differentiation (CD) 73 (L-VAP-2, lymphocyte vascular adhesion protein-2) and CD 90 (THY-1 Differentiation potential. All cell types from all donors underwent three lineage differentiation. Osteogenesis, quantified as amount of calcium deposited during 14 days of osteogenic media exposure, was higher for P2 BS and BC (mean 96.25 g/well BS) and lowest for P2 Syn (mean 5.95 g/well). However, for assays conducted using later passage (P5), the amount of deposited calcium decreased for all cell types. No statistically significant differences could be found between amount of calcium produced by cells from different tissues or donors in the same passage. Significant higher amount of calcium deposition was detected for cells in P2 compared to P5 ( Table 4) .
Adipogenetic differentiation BS and BC accumulated smaller droplets disposed in clusters, Syn and Adipo cells formed larger intracellular deposits within larger cells (Suppl.material Fig. 1) , quantitative spectrophotometer assessment of Oil Red O stained lipids showed a significant higher amount of lipids accumulated within Adipo comparing to Syn cells ( Table 4 Suppl. material). Chondrogenetic differentiation was quantified normalizing the amount of GAGs accumulation to pellet DNA content. Syn GAGs/DNA ratio was significant higher compared to BS, BC and Adipo cells. No significant differences were found between donors ( Table 5) . Histological examination of Safranin O stained pellets revealed a more organized fibber network at the peripheral part of Syn samples. Pellets produced by BS and BC cells had a more random collagen fibber orientation (Fig. 2) . Differentiated cells displayed histological aspect of adult chondrocyte (Fig. 3) .
Cell movement characteristics (distance, velocity, acceleration) were significantly higher for Adipo compared to Syn but not significantly different compared to BS cells (Table 5, 6 Supplementary material).
DISCUSSION
In this study, mesenchymal articular and periarticular tissues from elder donors were demonstrated to contain MSCs. Isolated cells were capable of proliferation and displayed stemness surface markers [26] . Exposed to specific media, isolated cells underwent three mesenchymal lineage differentiation. This is, to our knowledge, the first report of MSCs derived from adipose tissue were the only ones to display significant donor related growth parameters and cell yield. Number of Adipo MSCs as well as PD0 from one donor was significant higher. Syn, BS and BC MSCs yield and PD0 was homogenous among donors. It is possible the distinct growth potential of adipose derived stem cells to be related to the presence of adipokines within the OA joint and periarticular tissue. Lipid metabolism and the presence of leptin within osteoarthritic joints have been positively correlated with the progress of the disease [27, 28] . Currently there are no available data regarding proliferative potential of cells derived from periarticular adipose tissue in different stages of osteoarthritis. Abnormal fat accumulation is recognized as being responsive of painful periarticular deformities ("lipoarthrosis"), empirically associated with cartilage degradation. Whenever this tissue contains cells In this study BS and BC were slower to grow in primary culture and slower to form colonies. However, after the first passage the time in culture was similar for all cell types, suggesting that the initial cells isolated from bone were more deeply quiescent than their Adipo and Syn counterparts.
Cells were morphologically different depending on the tissue of origin but similar between same tissue types from all the donors. Cell surface markers associated with stemness (CD 105, CD 73, and CD 90) were present in all cell types and donors, except Adipo cells which showed heterogeneity in expression of CD 105, similar with reported data for ADSCs of young donor [32] . BS and BC cells showed expression of CD 146 in early passages (P2, P3, data not showed), but not in later passages (P5). CD 146 negative separation could be a method of obtaining homogenous population of bone derived cells starting from P0.
Expression of CD 34 in earlier passages (P2) by BS cells indicates an initial mixture of hematopoietic progenitor. All cell types from all donors displayed osteogenetic and chondrogenetic potential significantly higher in earlier passages (P2) than in later passages (P5). Syn cells retained higher potential in both passages for chondrogenesis not for osteogenesis. Late passages Syn cells could be used for cartilage regeneration. Freshly isolated MSCs or early passages can be used for bone augmentation procedures based on higher osteogenic potential. Syn cells showed the highest chondrogenic potential, compared to BS, BC and Adipo cells, with no significant differences between donors. Lower quantitative chondrogenesis (GAGs/DNA/pellet) obtained in this study compared to previous reports [33] could be age related. Syn MSCs cell harvest could be modulated using different cell seeding density [34] . It is possible differentiation capability could be modulated using similar strategies, to be further investigated.
Following a distinct characteristics movement of MSCs of different cells sources, cell movement in extended time lapse life cell imaging was tracked. Cell velocity, acceleration and distance were significant higher for Adipo than for Syn derived cells. There is an interesting parallel between cell kinetics and growth kinetics (CPD) of cells in same passage and similar tissue type. We found there is a direct correlation between recordable life tracking of non stained cells and their proliferative potential (Table 4, 5 Supplementary material). The correlation between cell motility and cell cycle progression [35] is to be further investigated. Being the fact that many components of the molecular machineries responsible for cell kinetics, cell proliferation and cell differentiation are shared, the potential of life imaging in prediction of cell individualities and fates under the integrative basis of their kinetic parameter analysis is yet to be explored.
We report the successful isolation of stem cells from three different mesenchymal adult human osteoarthritic tissues. Isolated cells have morphology, surface markers, proliferative and differentiation potential characteristic of MSCs. Mesenchymal tissues derived from late stage osteoarthritic donors were found to contain MSCs with distinct phenotypes. Trabecular bone, synovial and extraarticular adipose tissue resulting from total joint reconstructive procedures can be considered as cell sources for autologus regenerative strategies.
The principal limitation of this study is the number of biological replicates. Studies including larger number of donors are needed to validate present findings. Further comparison with age matched tissues obtained from non OA joints could derive important insights about disease pathogeny. Further investigation is needed as well to address the cause of donor related variability observed in adipose derived mesenchymal stem cells from OA subjects. The history of progression of OA in the operated joint, the presence of OA in other joints or the lifetime of the implanted prosthesis could be in correlation with bone and lipid metabolism.
Differentiation assays conducted in this study had the purpose in demonstrating the differentiation capability towards three mesenchymal lineages. If considered for regenerative cartilage therapies, there is a need to optimize differentiation protocols for obtaining hyaline cartilage. MSC capability of undergoing differentiation when seeded on scaffolds is another important question to be answered.
Characterization of OA MSCs has the potential of generating new targets for disease prevention and treatment. MSCs derived from OA mesenchymal tissues during joint reconstructive procedures can be used as accessible cell source for research and future RM therapies.
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